These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 22032060)

  • 1. Influence of cardiac rehabilitation on natriuretic peptides.
    Montiel-Trujillo A; Isasti-Aizpurua G; Carrasco-Chinchilla F; Jiménez-Navarro MF; Gómez-González A; Bravo Navas JC; Jimeno C; De Teresa-Galván E
    Acta Cardiol; 2011 Oct; 66(5):641-3. PubMed ID: 22032060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular remodelling in patients with moderate systolic dysfunction after myocardial infarction: favourable effects of exercise training and predictive role of N-terminal pro-brain natriuretic peptide.
    Giallauria F; Cirillo P; Lucci R; Pacileo M; De Lorenzo A; D'Agostino M; Moschella S; Psaroudaki M; Del Forno D; Orio F; Vitale DF; Chiariello M; Vigorito C
    Eur J Cardiovasc Prev Rehabil; 2008 Feb; 15(1):113-8. PubMed ID: 18277196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of N terminal-pro-brain (B-type) natriuretic peptide levels with exercise-based cardiac rehabilitation in patients with left ventricular dysfunction after myocardial infarction.
    Giallauria F; De Lorenzo A; Pilerci F; Manakos A; Lucci R; Psaroudaki M; D'Agostino M; Del Forno D; Vigorito C
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):625-32. PubMed ID: 16874155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EuroSCORE II and N-terminal pro-B-type natriuretic peptide for risk evaluation: an observational longitudinal study in patients undergoing coronary artery bypass graft surgery.
    Holm J; Vidlund M; Vanky F; Friberg Ö; Håkanson E; Walther S; Svedjeholm R
    Br J Anaesth; 2014 Jul; 113(1):75-82. PubMed ID: 24727704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction.
    Kubánek M; Goode KM; Lánská V; Clark AL; Cleland JG
    Eur J Heart Fail; 2009 Apr; 11(4):367-77. PubMed ID: 19179406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
    Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
    Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes.
    Coppola G; Corrado E; Mulè MC; Augugliaro S; Cucchiara A; Novo G; Amoroso G; Assennato P; Hoffmann E; Vitale F; Novo S
    Coron Artery Dis; 2009 May; 20(3):225-9. PubMed ID: 19387249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echocardiographic assessment and N-terminal pro-brain natriuretic peptide in hypertensives with metabolic syndrome.
    Krzesiński P; Uziebło-Życzkowska B; Gielerak G; Stańczyk A; Piotrowicz K; Piechota W; Smurzyński P; Skrobowski A
    Adv Clin Exp Med; 2017; 26(2):295-301. PubMed ID: 28791849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment.
    Hunt PJ; Richards AM; Nicholls MG; Yandle TG; Doughty RN; Espiner EA
    Clin Endocrinol (Oxf); 1997 Sep; 47(3):287-96. PubMed ID: 9373449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.
    Kremastinos DT; Hamodraka E; Parissis J; Tsiapras D; Dima K; Maisel A
    Am Heart J; 2010 Jan; 159(1):68-74. PubMed ID: 20102869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes undergoing left main percutaneous coronary intervention.
    Jaberg L; Toggweiler S; Puck M; Frank M; Rufibach K; Lüscher TF; Corti R
    Circ J; 2011; 75(11):2648-53. PubMed ID: 21891968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.
    Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A
    Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoterminal B-type pro-natriuretic peptide as a marker of recovery after high-risk coronary artery bypass grafting in patients with ischemic heart disease and severe impaired left ventricular function.
    Rothenburger M; Stypmann J; Bruch C; Wichter T; Hoppe M; Drees G; Berendes E; Huelsken G; Loeher A; Welp H; Röttger C; Schmid C; Scheld HH; Tjan TD
    J Heart Lung Transplant; 2006 May; 25(5):596-602. PubMed ID: 16678040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early changes in N-terminal pro-B-type natriuretic peptide levels after transcatheter aortic valve replacement and its impact on long-term mortality.
    Liebetrau C; Gaede L; Kim WK; Arsalan M; Blumenstein JM; Fischer-Rasokat U; Wolter JS; Kriechbaum S; Huber MT; van Linden A; Berkowitsch A; Dörr O; Nef H; Hamm CW; Walther T; Möllmann H
    Int J Cardiol; 2018 Aug; 265():40-46. PubMed ID: 29885699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
    Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
    J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of plasma norepinephrine and serum N-terminal pro-brain natriuretic peptide after exercise training predict survival in patients with heart failure.
    Rengo G; Pagano G; Parisi V; Femminella GD; de Lucia C; Liccardo D; Cannavo A; Zincarelli C; Komici K; Paolillo S; Fusco F; Koch WJ; Perrone Filardi P; Ferrara N; Leosco D
    Int J Cardiol; 2014 Feb; 171(3):384-9. PubMed ID: 24388546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal probrain natriuretic peptide in patients with acute coronary syndrome
.
    Kang Q; Wan Z; Huang Z
    Int J Clin Pharmacol Ther; 2017 Jan; 55(1):78-84. PubMed ID: 27879192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction.
    Costello-Boerrigter LC; Boerrigter G; Redfield MM; Rodeheffer RJ; Urban LH; Mahoney DW; Jacobsen SJ; Heublein DM; Burnett JC
    J Am Coll Cardiol; 2006 Jan; 47(2):345-53. PubMed ID: 16412859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.
    Vanderheyden M; Bartunek ; Claeys G; Manoharan G; Beckers JF; Ide L
    Clin Biochem; 2006 Jun; 39(6):640-5. PubMed ID: 16516185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
    David S; Kümpers P; Seidler V; Biertz F; Haller H; Fliser D
    Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.